346 related articles for article (PubMed ID: 15200157)
61. Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals.
Van Deun K; Van Cauteren H; Vandenberghe J; Canning M; Vanparys P; Coussement W
Adverse Drug React Toxicol Rev; 1997 Nov; 16(4):215-33. PubMed ID: 9608857
[TBL] [Abstract][Full Text] [Related]
62. Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study.
Fujii E; Kimura K; Mizoguchi K; Kato A; Takanashi H; Itoh Z; Omura S; Suzuki M
Toxicol Appl Pharmacol; 2008 Apr; 228(1):1-7. PubMed ID: 18355581
[TBL] [Abstract][Full Text] [Related]
63. XP-A cells complemented with Arg228Gln and Val234Leu polymorphic XPA alleles repair BPDE-induced DNA damage better than cells complemented with the wild type allele.
Porter PC; Mellon I; States JC
DNA Repair (Amst); 2005 Mar; 4(3):341-9. PubMed ID: 15661657
[TBL] [Abstract][Full Text] [Related]
64. Bioassay of mannitol and caprolactam and assessment of response to diethylnitrosamine in heterozygous p53-deficient (+/-) and wild type (+/+) mice.
Iatropoulos MJ; Jeffrey AM; Schlüter G; Enzmann HG; Williams GM
Arch Toxicol; 2001 Mar; 75(1):52-8. PubMed ID: 11357521
[TBL] [Abstract][Full Text] [Related]
65. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
Leung HW; Kamendulis LM; Stott WT
Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
[TBL] [Abstract][Full Text] [Related]
66. Genetically altered mouse models for identifying carcinogens.
Tennant RW; Stasiewicz S; Mennear J; French JE; Spalding JW
IARC Sci Publ; 1999; (146):123-50. PubMed ID: 10353386
[No Abstract] [Full Text] [Related]
67. Transgenic mice in carcinogenicity testing.
Griesemer R; Tennant R
IARC Sci Publ; 1992; (116):429-36. PubMed ID: 1428092
[TBL] [Abstract][Full Text] [Related]
68. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
Wells MY; Williams ES
Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
[TBL] [Abstract][Full Text] [Related]
69. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
70. Alternative models for carcinogenicity testing.
Cohen SM; Robinson D; MacDonald J
Toxicol Sci; 2001 Nov; 64(1):14-9. PubMed ID: 11606797
[TBL] [Abstract][Full Text] [Related]
71. A 24-month dietary carcinogenicity study of DAG (diacylglycerol) in rats.
Chengelis CP; Kirkpatrick JB; Bruner RH; Freshwater L; Morita O; Tamaki Y; Suzuki H
Food Chem Toxicol; 2006 Jan; 44(1):98-121. PubMed ID: 16084639
[TBL] [Abstract][Full Text] [Related]
72. Analysis of animal carcinogenicity experiments with multiple tumor types.
Lu Y; Malani HM
Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
[TBL] [Abstract][Full Text] [Related]
73. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
[TBL] [Abstract][Full Text] [Related]
75. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
[TBL] [Abstract][Full Text] [Related]
76. Toxicity and carcinogenicity studies of chlorpromazine hydrochloride and p-cresidine in the p53 heterozygous mouse model.
Petruska JM; Frank DW; Freeman GB; Evans EW; MacDonald JS
Toxicol Pathol; 2002; 30(6):696-704. PubMed ID: 12512871
[TBL] [Abstract][Full Text] [Related]
77. Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3F1 mice.
Beland FA; Benson RW; Mellick PW; Kovatch RM; Roberts DW; Fang JL; Doerge DR
Food Chem Toxicol; 2005 Jan; 43(1):1-19. PubMed ID: 15582191
[TBL] [Abstract][Full Text] [Related]
78. Use of non-mammalian species in bioassays for carcinogenicity.
Bunton TE
IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
[TBL] [Abstract][Full Text] [Related]
79. Detection of oxidative DNA damage, cell proliferation and in vivo mutagenicity induced by dicyclanil, a non-genotoxic carcinogen, using gpt delta mice.
Umemura T; Kuroiwa Y; Tasaki M; Okamura T; Ishii Y; Kodama Y; Nohmi T; Mitsumori K; Nishikawa A; Hirose M
Mutat Res; 2007 Sep; 633(1):46-54. PubMed ID: 17581771
[TBL] [Abstract][Full Text] [Related]
80. Lobucavir-induced proliferative changes in mice.
Woicke J; Durham SK; Mense MG
Exp Toxicol Pathol; 2007 Nov; 59(3-4):197-204. PubMed ID: 17942294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
